Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
On April 25th, 2023, the U.S. Food and Drug Administration (FDA) approved tofersen (BIIB067) for the treatment of amyotrophic lateral…
The first interim data has been published from a Phase I/II trial testing the safety and tolerability of AMT-130. If…
New treatment strategies are gaining attention in epilepsy, where current therapeutic options are ineffective for many. Learn more about the…